Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Sulfo-NHS-Biotin: Elevating Host-Pathogen Assays via Precisi
2026-07-20
Explore how Sulfo-NHS-Biotin enables precise, cell surface-targeted protein labeling for advanced host-pathogen interaction studies. Discover unique protocol insights, practical assay considerations, and real-world implications for affinity workflows using this versatile protein labeling reagent.
-
Synergistic Dual OXPHOS Disruption via LRPPRC and Dasatinib
2026-07-20
This study identifies a potent anti-tumor synergy between LRPPRC inhibition and dasatinib, disrupting mitochondrial oxidative phosphorylation (OXPHOS) through coordinated impairment of nuclear and mitochondrial gene expression. These findings present a mechanistically rational strategy for targeting OXPHOS-dependent cancers and inform future combination therapy design.
-
Lysis Buffer in Rapid Genotyping Kits: Workflows & Optimizat
2026-07-19
Unlock rapid, high-yield mouse genotyping with APExBIO's lysis buffer, a robust component engineered for DNA integrity and workflow speed. This guide translates bench experience and recent biomarker discoveries into actionable steps for reliable genetic analysis.
-
KR-12 Human Antimicrobial Peptide: Applied Protocols & Insig
2026-07-18
KR-12, the shortest human antimicrobial peptide derived from LL-37, offers targeted anti-biofilm and anti-inflammatory activity with low mammalian toxicity. This guide delivers actionable workflows, troubleshooting strategies, and new preclinical insights leveraging KR-12 (human) TFA from APExBIO for infection, inflammation, and wound-healing research.
-
Biotin-Free Proximity Labeling in Primary T Cells with BmTyr
2026-07-17
This study introduces a copper-dependent BmTyr tyrosinase platform enabling biotin-free, click-compatible proximity labeling in primary T cells. The innovation overcomes endogenous biotin background and enhances sensitivity and specificity in subcellular proteome profiling, with practical implications for dynamic protein interaction mapping in challenging cell systems.
-
AS1842856 Foxo1 Inhibitor: Reliable PI3K-Akt-Foxo1 Modulatio
2026-07-17
This article explores real-world challenges in cell-based metabolic and autophagy assays, highlighting how AS1842856 Foxo1 Inhibitor (SKU B8219) addresses reproducibility, specificity, and workflow optimization. Drawing on primary literature and validated best practices, it guides biomedical researchers in choosing, deploying, and interpreting AS1842856 in PI3K-Akt-Foxo1 pathway studies.
-
Topotecan (SKF104864): Translational Impact on Cancer Resear
2026-07-16
Explore how Topotecan, a potent topoisomerase I inhibitor, advances cancer research through unique mechanistic insights and translational strategies. Delve into its proven efficacy, advanced applications, and the latest clinical perspectives.
-
Nebivolol Hydrochloride in β1-Adrenoceptor Antagonist Resear
2026-07-16
Nebivolol hydrochloride delivers unmatched selectivity for β1-adrenoceptor antagonist studies, enabling precise dissection of cardiac signaling without off-target effects. This article details optimized workflows, troubleshooting strategies, and key experimental insights for advanced cardiovascular pharmacology research.
-
Targeted Amikacin Delivery to Granulomas Using Dendritic Cel
2026-07-15
This study pioneers a dendritic cell-mediated approach for delivering Amikacin directly into mycobacterial granulomas, achieving localized antibiotic concentrations without detectable systemic exposure. The findings suggest a promising adjunct strategy for overcoming the challenges of antibiotic resistance and toxicity in nontuberculous mycobacterial infections.
-
Mechanisms of Propranolol’s Anti-Tremor Action in Essential
2026-07-15
This article reviews a recent study that clarifies how propranolol and primidone alleviate essential tremor (ET) symptoms using advanced neurophysiological techniques. The findings highlight distinct central mechanisms for each drug, deepening understanding of ET pharmacotherapy and informing future translational research.
-
Mycophenolic Acid as a Dehydrogenase Inhibitor in Immune Ass
2026-07-14
Mycophenolic acid enables precise modulation of immune cell metabolism within standardized whole-blood stimulation protocols. Explore advanced workflow parameters, troubleshooting strategies, and unique advantages in immunometabolism and apoptosis research using this high-purity dehydrogenase inhibitor.
-
4-Hydroxytamoxifen: Protocol Parameters for Research Workflo
2026-07-14
4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator optimized for DMSO-based protocols in breast cancer, prostate cancer, and cardiac myocyte calcium handling research. It is unsuitable for protocols requiring aqueous or ethanol solubility, and correct handling and storage are critical to maintaining reagent integrity and reproducibility.
-
Cathepsin S Mutations Shape Antigen Processing in Lymphoma
2026-07-13
Dheilly et al. (2020) uncover how cathepsin S (CTSS) overexpression and a recurrent activating mutation regulate antigen processing and T cell dynamics in non-Hodgkin lymphoma. This work highlights the non-redundant role of CTSS in modulating immune surveillance and suggests that targeted cysteine protease inhibition may enhance tumor immunogenicity.
-
Thrombin B Chain Fragment: Mechanism, Evidence & Benchmarks
2026-07-13
Thrombin, a key trypsin-like serine protease, drives clot formation by converting fibrinogen to fibrin. The B chain fragment from APExBIO offers >99% purity for precise research. Its multifaceted roles span coagulation, platelet activation, and vascular pathology.
-
Applied Use-Cases of 5-(N,N-dimethyl)-Amiloride Hydrochlorid
2026-07-12
5-(N,N-dimethyl)-Amiloride hydrochloride enables high-precision modulation of Na+/H+ exchanger pathways, empowering translational research into vascular injury and intracellular pH regulation. This guide bridges advanced biomarker discovery with optimized experimental protocols and troubleshooting for robust, reproducible results.